Karagas MR - Search Results

1

Hair dye use and risk of bladder cancer in the New England bladder cancer study.

Koutros S, Silverman DT, Baris D, Zahm SH, Morton LM, Colt JS, Hein DW, Moore LE, Johnson A, Schwenn M, Cherala S, Schned A, Doll MA, Rothman N, Karagas MR. Koutros S, et al. Among authors: karagas mr. Int J Cancer. 2011 Dec 15;129(12):2894-904. doi: 10.1002/ijc.26245. Epub 2011 Aug 12. Int J Cancer. 2011. PMID: 21678399 Free PMC article.

2

Microsatellite instability at tetranucleotide repeats in skin and bladder cancer.

Danaee H, Nelson HH, Karagas MR, Schned AR, Ashok TD, Hirao T, Perry AE, Kelsey KT. Danaee H, et al. Among authors: karagas mr. Oncogene. 2002 Jul 25;21(32):4894-9. doi: 10.1038/sj.onc.1205619. Oncogene. 2002. PMID: 12118368

3

Sampling private wells at past homes to estimate arsenic exposure: a methodologic study in New England.

Colt JS, Baris D, Clark SF, Ayotte JD, Ward M, Nuckols JR, Cantor KP, Silverman DT, Karagas M. Colt JS, et al. J Expo Anal Environ Epidemiol. 2002 Sep;12(5):329-34. doi: 10.1038/sj.jea.7500235. J Expo Anal Environ Epidemiol. 2002. PMID: 12198581

4

Bladder cancer risk and personal hair dye use.

Andrew AS, Schned AR, Heaney JA, Karagas MR. Andrew AS, et al. Among authors: karagas mr. Int J Cancer. 2004 Apr 20;109(4):581-6. doi: 10.1002/ijc.11729. Int J Cancer. 2004. PMID: 14991581

5

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer.

Kelsey KT, Hirao T, Schned A, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR. Kelsey KT, et al. Among authors: karagas mr. Br J Cancer. 2004 Apr 19;90(8):1572-6. doi: 10.1038/sj.bjc.6601748. Br J Cancer. 2004. PMID: 15083187 Free PMC article.

6

Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.

Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A. Karagas MR, et al. Cancer Causes Control. 2004 Jun;15(5):465-72. doi: 10.1023/B:CACO.0000036452.55199.a3. Cancer Causes Control. 2004. PMID: 15286466

7

Occupation and bladder cancer risk in a population-based case-control study in New Hampshire.

Colt JS, Baris D, Stewart P, Schned AR, Heaney JA, Mott LA, Silverman D, Karagas M. Colt JS, et al. Cancer Causes Control. 2004 Oct;15(8):759-69. doi: 10.1023/B:CACO.0000043426.28741.a2. Cancer Causes Control. 2004. PMID: 15456989

8

Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.

Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT. Karagas MR, et al. Cancer Lett. 2005 Feb 28;219(1):63-9. doi: 10.1016/j.canlet.2004.10.006. Cancer Lett. 2005. PMID: 15694665

9

TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer.

Kelsey KT, Hirao T, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Colt J, Baris D, Morris JS, Schned A, Karagas M. Kelsey KT, et al. Int J Cancer. 2005 Nov 10;117(3):370-5. doi: 10.1002/ijc.21195. Int J Cancer. 2005. PMID: 15906354

10

Carcinogen exposure and gene promoter hypermethylation in bladder cancer.

Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT. Marsit CJ, et al. Among authors: karagas mr. Carcinogenesis. 2006 Jan;27(1):112-6. doi: 10.1093/carcin/bgi172. Epub 2005 Jun 29. Carcinogenesis. 2006. PMID: 15987713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

561 results

Search Page

Filters